To the central content area :::
:::Listed Companies > Listed Companies Info. > Main Board Companies > Listed Company Profile

General Stock Board Listed Company Profile

Company Profile
Chairman CEO Spokesperson Tel Address Date of Listing (Regular)
Shan-Ney Huang Chih-Hui Cheng Chih-Hui Cheng 02-27031098 11F., No.236, Sec. 4, Xinyi Rd., Da' an Dist., Taipei City 106, TaiwanTaipei, Taiwan 2011/09/23
Industry Main Business
Biotechnology and Medical Care Oneness Biotech is dedicated to develop first-in-class and best-in-class new drugs to fulfil unmet medical need in chronic dermatologic and immunological disorders. With the established proprietary platform, Oneness can develop antibodies with high affinity and specificity in an efficient manner and is with full capacity to propel pipeline development from preclinical to clinical stages. Its lead drugs for diabetic foot ulcers has been approved by Taiwan FDA in March 2021 and being launched into the global market. Oneness further drives the pipeline into different clinical stages where 1 botanical new drug is under phase 3 and Fast Track designation in the U.S., 2 antibodies under phase 2 studies and 1 small molecule under phase 1 study. By upholding its business principle to create and share "health, happiness, and love" with commitment in "developing new drugs and caring for life", Oneness continuously takes initiatives to turn innovation into medicines for the benefits of patients.
Market Information ( 2023/09/22 )
Shr. Vol. Highest Lowest Closed Change Transaction TurnOver(%) long
1043.259 177.00  174.00  176.50  0.00  1239 13,022 57
Trading method Fun
price or
on T day
Announcement of Irregularity
TPEx measures
With warrants Can be shorted or margined? Detail
Normal N N N N Y Today History
Financial Reports
Cash Flows Items
(NT$ thousand)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
Comprehensive Income Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Other comprehensive income
Comprehensive income
Basic earnings per share
 Auditor's report on latest financial statements: auditor's report:
 More detail:MOPS
 Foreign issuers’ information is disclosed in consolidated statements.